Dale A. Sander insider trades
Open-market stock purchases and sales by Dale A. Sander, CFO and Chief Corp. Dev. Off at Humacyte, Inc, from SEC Form 4 filings since Aug 26, 2021.
Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -43%.
Companies traded
- HUMA Humacyte, Inc: 3 buys, 2 sales, last May 18, 2026